The Latest Cardiac and Vascular News
Los Angeles, CA, July 21, 2020 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”), today announced the Company’s registration statement on Form S-1 relating to its equity credit line with Calvary Fund I LP has been ordered effective by the Securities and Exchange Commission. This equity […]
Collaboration will Combine MyoKardia’s Leading Precision Cardiovascular R&D Platform with Fulcrum’s Proprietary Product Engine to Identify Targets that Modulate Gene Expression BRISBANE, Calif. and CAMBRIDGE, Mass., July 21, 2020 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company discovering and developing targeted therapies for the treatment of serious […]
– Novel gene therapy designed to stimulate formation of new coronary blood vessels is being studied in patients with treatment-resistant angina with no remaining treatment options – July 21, 2020 07:00 AM Eastern Daylight Time MALVERN, Pa.–(BUSINESS WIRE)–XyloCor Therapeutics today announced it has successfully dosed the first two patients in […]
MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today announced the expansion of its Board of Directors with the appointment of Steven Boyd and Keith Maher, M.D. Both Directors […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. today announced that its flagship product, Paragonix SherpaPak™ Cardiac Transport System (CTS), is the recipient of a prestigious international design award: the Red Dot Award. The traditional mechanism by which organs are transported (bagged on ice in a consumer cooler) has remained unchanged for more than […]
Sanifit to start new clinical development program of SNF472 in End Stage Kidney Disease patients with Peripheral Artery Disease FDA has agreed to key aspects of the clinical program, including the primary endpoint for the single pivotal phase 3 study There are approximately 175,000 and 150,000 ESKD patients with PAD […]
SANTA CLARA, Calif., July 20, 2020 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that Maria Sainz has joined its Board of Directors and will serve on Shockwave’s Compensation Committee. “I am delighted […]
WARRINGTON, Pa., July 20, 2020 /PRNewswire/ — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today announced John Hamill has been appointed Senior Vice President, Chief Financial Officer. In this role, Mr. Hamill will […]
Both Companies Committed to Bringing the Best Cardiac Care to the Healthcare Workers and Patients that Need It TOTOWA, New Jersey, July 16, 2020 /PRNewswire/ — GS Elektromedizinische Geraete G. Stemple GmbH, marketing defibrillators under the corpuls brand, and VectraCor Inc., announced today that they have concluded a licensing agreement allowing corpuls to incorporate VectraCor’s […]
Next generation sutureless surgical technology is based on a clinically proven platform and has been designed to provide valve durability LONDON – ( BUSINESS WIRE ) – LivaNova PLC (NASDAQ: LIVN), a leading medical technology and innovation company, announced today that the Perceval ® Plus Advanced Suture-Free Surgical Aortic Valve is now available for a commercial […]
